Hormone replacement therapy - Current recommendations. 2022

Kugajeevan Vigneswaran, and Haitham Hamoda
King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK.

Menopause is a major life event that can affect women in several ways. Its onset marks the end of the reproductive life cycle, and its impact can be both short and long term. Menopause is often a gradual process, preceded by a transitional period known as perimenopause. The average age of menopause in the UK is 51. The clinical manifestations of menopause result from the eventual exhaustion of oocytes within the ovaries. This leads to a chronic hypo-estrogenic state, which in the short term causes menopausal symptoms and over a long term, has an impact on bone and cardiovascular health. There has been a steep drop in the prescription of hormone replacement therapy (HRT) following the publication of the Women's Health Initiative Study and the Million Women Study. It is currently estimated that approximately a million women in the UK are taking HRT for control of their menopausal symptoms. This review summarises the current recommendations for HRT use in menopausal women. The benefits of HRT in improving the symptoms of menopause are discussed as well as the potential role of HRT in managing long-term sequelae is covered. Evidence pertaining to the potential risks associated with HRT is also be reviewed.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015914 Estrogen Replacement Therapy The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy. Hormone Replacement Therapy, Post-Menopausal,Postmenopausal Hormone Replacement Therapy,Replacement Therapy, Estrogen,Estrogen Progestin Combination Therapy,Estrogen Progestin Replacement Therapy,Estrogen Replacement,Replacement, Estrogen,Therapy, Estrogen Replacement,Estrogen Replacement Therapies,Estrogen Replacements,Hormone Replacement Therapy, Post Menopausal,Replacement Therapies, Estrogen,Replacements, Estrogen,Therapies, Estrogen Replacement
D016387 Women's Health The concept covering the physical and mental conditions of women. Woman's Health,Womens Health,Health, Woman's,Health, Women's,Health, Womens
D047648 Perimenopause The transitional period before and after MENOPAUSE. Perimenopausal symptoms are associated with irregular MENSTRUAL CYCLE and widely fluctuated hormone levels. They may appear 6 years before menopause and subside 2 to 5 years after menopause.
D020249 Hormone Replacement Therapy Therapeutic use of hormones to alleviate the effects of hormone deficiency. Replacement Therapy, Hormone,Therapy, Hormone Replacement,Hormone Replacement Therapies,Replacement Therapies, Hormone,Therapies, Hormone Replacement

Related Publications

Kugajeevan Vigneswaran, and Haitham Hamoda
May 1999, Revue medicale de Liege,
Kugajeevan Vigneswaran, and Haitham Hamoda
June 2004, Climacteric : the journal of the International Menopause Society,
Kugajeevan Vigneswaran, and Haitham Hamoda
May 1988, Mayo Clinic proceedings,
Kugajeevan Vigneswaran, and Haitham Hamoda
August 2003, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Kugajeevan Vigneswaran, and Haitham Hamoda
January 2005, Lancet (London, England),
Kugajeevan Vigneswaran, and Haitham Hamoda
December 2019, Minerva ginecologica,
Kugajeevan Vigneswaran, and Haitham Hamoda
November 2003, Clinical endocrinology,
Kugajeevan Vigneswaran, and Haitham Hamoda
April 2017, Nature reviews. Endocrinology,
Kugajeevan Vigneswaran, and Haitham Hamoda
April 2003, Minerva ginecologica,
Kugajeevan Vigneswaran, and Haitham Hamoda
March 2003, Clinical endocrinology,
Copied contents to your clipboard!